Kura Oncology KURA Shares (Basic)
Shares (Basic) at other companies
Other financials
Where this comes from
Reported directly by Kura Oncology in its filing.
Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.
The official record: Kura Oncology’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Kura Oncology's shares (basic).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Kura Oncology's shares (basic)?
- Kura Oncology (KURA) reported shares (basic) of 88.6M in Q1 2026.
- How has Kura Oncology's shares (basic) changed year-over-year?
- Kura Oncology's shares (basic) increased by 1.4% year-over-year, from 87.4M to 88.6M.
- What is the long-term trend for Kura Oncology's shares (basic)?
- Over 3 years (2022 to 2025), Kura Oncology's shares (basic) has grown at a 9.5% compound annual growth rate (CAGR), from 267.2M to 350.3M.
- What does shares (basic) mean?
- The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.